Amy K. Patick
Amplyx Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, Viral Infections and Immunology Research, HIV Research and Treatment, Hepatitis C virus research, Respiratory viral infections research
Most-Cited Works
- → Treatment of HCV Infection by Targeting MicroRNA(2013)2,162 cited
- → Viracept (Nelfinavir Mesylate, AG1343): A Potent, Orally Bioavailable Inhibitor of HIV-1 Protease(1997)619 cited
- → The Relation between Baseline HIV Drug Resistance and Response to Antiretroviral Therapy: Re-Analysis of Retrospective and Prospective Studies Using a Standardized Data Analysis Plan(2000)330 cited
- → Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes(1999)316 cited
- → HIV Capsid is a Tractable Target for Small Molecule Therapeutic Intervention(2010)298 cited
- → Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial(2017)261 cited